Patents Assigned to Universität Wien
-
Patent number: 10736820Abstract: Radically polymerizable dental material, which contains at least one sulphonic acid ester of Formula 1: in which A is H, CN, an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical or a combination thereof; X is COO— or —CON(R1)— or is absent; B is an aromatic, cycloaliphatic, linear or branched aliphatic C1-C30-hydrocarbon radical, or a combination thereof; R1 is hydrogen or an aromatic, cycloaliphatic, linear or branched aliphatic C1-C10-hydrocarbon radical; m is an integer from 1 to 6, n is an integer from 1 to 6 and p is an integer from 1 to 6; wherein m and p cannot simultaneously be greater than 1. The compounds of Formula 1 are active as chain transfer agents in radical polymerization.Type: GrantFiled: May 2, 2016Date of Patent: August 11, 2020Assignees: Ivoclar Vivadent AG, Technicshe Universität WienInventors: Norbert Moszner, Iris Lamparth, Urs Karl Fischer, Kai Rist, Peter Burtscher, Robert Liska, Christian Gorsche, Konstanze Seidler
-
Patent number: 10732097Abstract: A photothermal interferometry apparatus and method for detecting a molecule in a sample, in particular for detecting a trace gas species, comprising: a Fabry-Perot interferometer with a first mirror, a second mirror and a first cavity for containing the sample extending between the first and the second mirror, a probe laser for passing a probe laser beam through the first cavity of the Fabry-Perot interferometer, an excitation laser for passing an excitation laser beam through the first cavity of the Fabry-Perot interferometer for exciting the molecule in the sample, and a photodetector unit for detecting the transmitted probe laser beam passed through the first cavity of the Fabry-Perot interferometer.Type: GrantFiled: July 12, 2017Date of Patent: August 4, 2020Assignee: TECHNISCHE UNIVERSITÄT WIENInventors: Johannes Paul Waclawek, Bernhard Lendl
-
Patent number: 10723748Abstract: The present invention relates to novel monomaleimide-functionalized platinum compounds of formula (I), including in particular novel monomaleimide-functionalized oxaliplatin and carboplatin derivatives, as well as their use as medicaments, particularly for the treatment or prevention of cancer.Type: GrantFiled: December 9, 2016Date of Patent: July 28, 2020Assignees: Medizinische Universität Wien, Universität WienInventors: Christian Kowol, Petra Heffeter, Walter Berger, Bernhard K. Keppler, Josef Mayr, Verena Pichler
-
Patent number: 10709827Abstract: A substance exchange device for intracorporal use includes a cavity for receiving blood having at least one blood inlet and at least one blood outlet, a substance exchange membrane adjoining the cavity, a supply duct for supplying an exchange fluid to the substance exchange membrane, a blood pump arranged within the cavity and a drive unit for the blood pump. The blood pump is configured to pump blood in a direction from a blood inlet to a blood outlet of the cavity. The drive unit includes a turbine, which is connected to the supply duct and may be driven by an exchange fluid supplied via the supply duct, where the turbine includes at least a rotor coupled to the blood pump and a stator (turbine nozzle) arranged upstream of the rotor.Type: GrantFiled: April 11, 2018Date of Patent: July 14, 2020Assignee: TECHNISCHE UNIVERSITÄT WIENInventors: Christoph Janeczek, Margit Gföhler, Michael Harasek
-
Patent number: 10709778Abstract: The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans and animals including mammals and birds. More particularly, it relates to subunit vaccines that are effective against pathogens causing infections thereof for use in humans and animals including mammals and birds. The present invention specifically provides a novel vaccine formulation suitable for ocular immunization comprising a subunit vaccine antigen in an amount to provoke a protective immune response and at least two adjuvants of which one is corpuscular. It further provides a method for inducing a local and systemic immune response and methods for preventing recurrence of ocular infections and/or modulates the occurrence and/or severity of sequels.Type: GrantFiled: April 24, 2014Date of Patent: July 14, 2020Assignee: MEDIZINISCHE UNIVERSITÄT WIENInventors: Talin Barisani-Asenbauer, Aleksandra Inic-Kanada
-
Patent number: 10704553Abstract: Disclosed is a magnetic coupling for transmitting torque along an axis of rotation, comprising two coupling parts which can be rotated relative to each other, wherein a drive-side coupling part has a drive-side permanent magnet and wherein an output-side coupling part has an output-side permanent magnet that lies opposite and at a distance from the drive-side permanent magnet along the axis of rotation. One of the coupling parts comprises a diverting element which is at least partially ferromagnetic and is non-rotatably connected to the permanent magnet of said coupling part and one part of the diverting element is disposed radially outside the opposite permanent magnet.Type: GrantFiled: May 13, 2015Date of Patent: July 7, 2020Assignee: TECHNISCHE UNIVERSITÄT WIENInventors: Christoph Janeczek, Markus Hinteregger
-
Publication number: 20200149604Abstract: Monolithic phononic crystal for vibration isolation comprising: a two-dimensional array of a plurality of resonant masses, said resonant masses being connected by bridges; wherein transition regions between bridges and resonant masses have a concave shape in the plane of the two-dimensional array, respectively; wherein the resonant masses each have convex edges in the plane of the two-dimensional array; wherein the bridges are recessed with respect to the thickness of the resonant masses.Type: ApplicationFiled: November 7, 2019Publication date: May 14, 2020Applicant: Universität WienInventors: Ralf Riedinger, Mathias Dragosits
-
Patent number: 10605885Abstract: The disclosed subject matter relates to a method for determining phase offsets in a complex-valued image in Magnetic Resonance Imaging, including the steps of, immobilising an object and acquiring a first image thereof at a predetermined first echo time and a second image thereof at a predetermined second echo time, the first and second images being separated into first and second magnitude images and first and second phase images, respectively, wherein a ratio between said first echo time and said second echo time is chosen to be n:(n+1), n being a positive integer; generating, pixel by pixel, a phase evolution image; and subtracting, pixel by pixel, an n-fold of the phase evolution image from the first phase image to obtain a phase offset image containing said phase offsets.Type: GrantFiled: June 9, 2017Date of Patent: March 31, 2020Assignee: MEDIZINISCHE UNIVERSITÄT WIENInventors: Simon Robinson, Korbinian Eckstein
-
Patent number: 10591480Abstract: Disclosed is a method for the detection of an IgM antibody specific for a flavivirus in a sample, comprising the steps of (a) contacting the sample with a solid support comprising immobilised IgM-binding molecules, (b) allowing binding of IgM antibodies in the sample to the IgM binding molecules on the solid support so that the IgM antibodies are also immobilised on the solid support, and (c) detecting IgM antibodies specific for a flavivirus by allowing binding of a complex comprising (i) an antiparallel dimer of soluble flavivirus Protein E (sE) and (ii) a marker and identifying the binding of the complex to the specific flavivirus IgM antibody by detecting the marker; and a kit suitable for performing the method.Type: GrantFiled: June 2, 2017Date of Patent: March 17, 2020Assignee: MEDIZINISCHE UNIVERSITÄT WIENInventors: Franz X. Heinz, Karin Stiasny
-
Patent number: 10563013Abstract: A solvothermal synthesis process for polyimides is provided. The process uses solution polymerization of monomers in an appropriate solvent, by mixing the solvent and the monomers and heating the mixture under pressure at temperatures exceeding the respective boiling point at normal pressure. The process produces essentially completely crystalline polyimides by a) mixing and heating the solvent and the monomers by either (i) heating the solvent up to solvothermal conditions and subsequently adding the monomers to initiate the reaction, or (ii) mixing the monomers with the solvent and heating the mixture up to solvothermal conditions within a period of 5 min, the reaction temperature TR being held below the solid-state polymerization temperature TP of the monomers during the polymerization; and b) carrying out the solution polymerization until essentially complete conversion is achieved.Type: GrantFiled: May 13, 2016Date of Patent: February 18, 2020Assignee: Technische Universität WienInventors: Miriam Margarethe Unterlass, Bettina Baumgartner
-
Publication number: 20200049597Abstract: An apparatus and a method for analysing a solid specimen material by means of ablating particles of the solid specimen material by laser into a carrier liquid, having: a specimen holder for arranging the solid specimen material covered by the carrier liquid, a laser apparatus for irradiating the solid specimen material to produce a suspension of particles of the solid specimen material and the carrier liquid, an analysis apparatus for analysing the particles, an ablation cell with the specimen holder, having a liquid channel for the carrier liquid and having an entry window made of a material that transmits the laser beam, a supply line for supplying the carrier liquid into the liquid channel of the ablation cell and a discharge line for discharging the suspension of particles of the solid specimen material and the carrier liquid from the liquid channel of the ablation cell into the analysis apparatus.Type: ApplicationFiled: October 5, 2017Publication date: February 13, 2020Applicant: Technische Universität WienInventors: Andreas LIMBECK, Maximilian BONTA, Johannes FRANK
-
Patent number: 10558173Abstract: The invention relates to a method for producing a reference frequency ?f. According to the invention, the use of a first optical resonator (3a; 24) and of a second optical resonator (25) is provided, wherein the first resonator (3a; 24) has a first resonator mode having a first frequency f1 and the second resonator (25) has a second resonator mode having a second frequency f2, wherein the frequencies of the two resonator modes are functions of an operating parameter BP and assume the values f1 and f2 at a specified value BP0 of the operating parameter such that f1(BP0)=f1 and f2(BP0)=f2 apply, wherein the resonators (3a; 24, 25) are designed in such a way that the respective first derivatives of the frequencies f1(BP), f2(BP) with respect to BP or at least respective difference quotients around BP0 correspond within a deviation of at most ±0.Type: GrantFiled: April 5, 2017Date of Patent: February 11, 2020Assignee: Technisch Universität WienInventor: Michael Trupke
-
Patent number: 10527547Abstract: The invention relates to a method and to a device for determining a material property, in particular the aging state or the aging resistance, of a bitumen material, comprising the steps: applying a substantially monochromatic first excitation radiation of a first excitation wavelength to the bitumen material; measuring the intensity of a first fluorescence radiation, excited by the first excitation radiation, at a measurement wavelength; applying a substantially monochromatic second excitation radiation of a first excitation wavelength to the bitumen material; measuring the intensity of a second fluorescence radiation, excited by the second excitation radiation, at the measurement wavelength; determining a first key figure for the material property of the bitumen material from the ratio between the intensity of the second fluorescence radiation to the intensity of the first fluorescence radiation.Type: GrantFiled: June 22, 2016Date of Patent: January 7, 2020Assignee: TECHNISCHE UNIVERSITÄT WIENInventors: Bernhard Hofko, Markus Hospodka, Josef Fuessl, Lukas Eberhardsteiner, Hinrich Grothe, Florian Handle, Daniel Grossegger, Ronald Blab
-
Patent number: 10383955Abstract: The present invention relates to a human mast cell line corresponding to deposit number CNCM I-4551 and also to the lines derived therefrom, in particular the derived lines corresponding respectively to deposit numbers CNCM I-4552 and CNCM I-4553, and to the uses thereof, in particular for screening for compounds of therapeutic interest.Type: GrantFiled: November 2, 2012Date of Patent: August 20, 2019Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, ECOLE NORMALE SUPERIEURE DE CACHAN, MEDIZINISCHE UNIVERSITAT WIENInventors: Michel Arock, Peter Valent, Rosine Saleh, Ghaith Wedeh, Christian Auclair
-
Publication number: 20190226011Abstract: The present invention relates to a method for the in vitro detection of a latent tuberculosis infection (LTBI) in a subject, wherein said method comprises determining at least one nucleotide sequence and/or at least one polypeptide of Mycobacterium tuberculosis (Mtb) in a blood cell population of said subject, and wherein the presence of said at least one nucleotide sequence and/or said at least one polypeptide is indicative for said latent tuberculosis infection. In particular, the blood cell population is enriched for hematopoietic stem cells. The invention also relates to a pharmaceutical composition for use in the treatment of the LTBI in the subject, wherein it is determined if the nucleotide sequence and/or the polypeptide of Mtb is/are present in the blood cell population. Further, the invention relates to kits for carrying out the methods of the invention. The invention also relates to the use of the kits.Type: ApplicationFiled: June 6, 2017Publication date: July 25, 2019Applicants: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., Medizinische Universität WienInventors: Julia Tornack, Steephen REECE, Fritz MELCHERS, Stefan H.E. KAUFMANN, Wolfgang BAUER, Georg STINGL
-
Patent number: 10357537Abstract: The present invention relates to a pharmaceutical composition comprising a cyclotide for use in immune suppression as well as to a method for immune suppression comprising the step of administering an effective amount of a pharmaceutical composition comprising such a cyclotide to a subject in need thereof. The present invention also relates to a pharmaceutical composition comprising a cyclotide for use in treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation. Likewise, the present invention also relates to a method for treating or preventing a disorder selected from the group consisting of (i) an autoimmune disorder; (ii) a hypersensitivity disorder; and (iii) a lymphocyte-mediated inflammation.Type: GrantFiled: October 30, 2018Date of Patent: July 23, 2019Assignees: Medizinische Universitat Wien, Universitatsklinikum FreiburgInventors: Christian Werner Gruber, Carsten Gruendemann
-
Patent number: 10358468Abstract: The present invention relates to a pharmaceutical composition comprising complement split product C4d for use in treating an inflammatory condition, such as graft rejection, graft versus host disease, an autoimmune disease or atopy. The C4d to be used may be a multimer. Accordingly, also C4d multimers and their use in medicine, like the treatment of inflammatory conditions, is provided. Furthermore, the present invention provides a protein complex comprising C4d interacting with its ILT4 receptor. This protein complex may be used in screening methods Also antibodies specifically binding to the C4d multimer or the C4d/ILT4-protein complex are subject of the present invention.Type: GrantFiled: March 8, 2018Date of Patent: July 23, 2019Assignee: Medizinische Universität WienInventors: Johannes Hofer, Peter Steinberger, Gerhard Zlabinger, Georg Böhmig, Florian Forster, Judith Leitner, Markus Wahrmann, Margarethe Merio, Johannes Kovarik, Markus Hölzl, David E. Isenman
-
Patent number: 10350281Abstract: The invention discloses a method for producing a single bacterial strain culture of Histomonas meleagridis (H. meleagridis), the method being characterised by the following steps: (a) providing a xenic culture of H. meleagridis comprising H. meleagridis cells with a wild type bacterial flora, (b) treating the xenic culture with a mixture of antibiotics thereby killing the wild type bacterial flora, (c) centrifuging and washing the H. meleagridis cells, (d) controlling effectiveness of step (b), (e) resuspending the washed H. meleagridis cells, (f) adding one or more single bacterial strain(s) to the resuspended H. meleagridis cells, and (g) culturing the one or more single bacterial strain(s) with the resuspended H. meleagridis cells so as to obtain a single bacterial strain culture of H. meleagridis.Type: GrantFiled: November 2, 2017Date of Patent: July 16, 2019Assignee: VETERINARMEDIZINISCHE UNIVERSITAT WIENInventors: Michael Hess, Petra Ganas
-
Patent number: 10342744Abstract: Radically polymerizable dental material, which contains at least one compound of Formula I: The material preferably additionally contains a radically polymerizable monomer, an initiator for the radical polymerization and filler. It is characterized by a low polymerization contraction stress.Type: GrantFiled: July 9, 2015Date of Patent: July 9, 2019Assignees: Ivoclar Vivadent AG, Technische Universität WienInventors: Norbert Moszner, Urs-Karl Fischer, Iris Lamparth, Peter Burtscher, Robert Liska, Christian Gorsche, Konstanze Seidler, Paul Gauss
-
Patent number: 10331012Abstract: An apparatus for generating narrow-band single and multi-photon state with long coherence length is disclosed. The apparatus comprises a laser pump (20) producing laser light, a non-linear optical crystal (30) within an optical cavity (40), wherein the optical cavity (40) comprises at least two mirrors (42, 44); and a tuning crystal (50) situated between the non-linear optical crystal (30) and a first one (42) of the at least two mirrors.Type: GrantFiled: March 9, 2017Date of Patent: June 25, 2019Assignee: Universität WienInventors: Amir Moqanaki, Francesco Massa, Philip Walther